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The gastrointestinal microbiota has an important role in human health. Dietary interventions are of great interest to modulate the 
composition and metabolic functions of the gut microbial communities and to improve health, and prevent or treat diseases. Con-
sumption of prebiotics is one dietary strategy for beneficial manipulation of the gut microbiota, because it allows increasing the 
fibre intake, especially in people with western dietary habits, who do not take the recommended daily amount of fiber. Interestingly, 
milk peptides can also positively affect the beneficial gut microorganisms. The present work is a pilot study aimed to investigate 
the effect of a prebiotic supplementation on composition and metabolic activity of microorganisms living in the human gut. In 
this trial, 12 healthy subjects received 10g/die of supplement Biotransit®, composed by corn derived dextrin and milk peptides, 
produced and marketed in Italy by Depofarma (Italy), for 4 weeks with a 2 weeks washout. Outcome measures were assessed 
at four time points (before the supplementation T0-1, T0-2, at the end of intervention, T30 and after washout, T45), including 
gut microbiota profiling by 16S rRNA gene sequencing and intestinal functional metabolism measuring faecal Short Chain Fatty 
Acid concentrations (SCFAs). The effects of the Biotransit supplementation on bifidobacteria were also assessed with culture de-
pendent techniques. Gut microbiota analysis revealed that Biotransit® supplementation after 30 days did not exert effects on the 
overall gut microbiota structure. Although no significant differences on alpha diversity were obtained, we observed an increase of 
diversity after 30 days of treatment. Beta diversity analysis, calculated on Bray-Curtis distances revealed significant differences 
comparing T0 vs T45 and T30 vs T45. Interestingly, at T45, we found an enrichment of Porphyromonadaceae. Biotransit® induced 
quantitative changes in cultivable bifidobacteria with increased amount at T45, even if the total number of species has not been 
influenced. Biotransit® supplementation is also associated to an increase total SCFAs concentration in T30 and T45, in particular 
related to acetate, propionate and butyrate (p < 0.05). Future study will be aimed to follow the time course of the persistence of 
this effect after the end of treatment. 
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